Corient Private Wealth’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $878K | Sell |
75,396
-1,441
| -2% | -$16.8K | ﹤0.01% | 1498 |
|
|
2025
Q1 | $571K | Sell |
76,837
-10,811
| -12% | -$80.3K | ﹤0.01% | 1535 |
|
|
2024
Q4 | $525K | Buy |
87,648
+643
| +0.7% | +$3.86K | ﹤0.01% | 1589 |
|
|
2024
Q3 | $445K | Buy |
87,005
+5,261
| +6% | +$26.9K | ﹤0.01% | 1777 |
|
|
2024
Q2 | $296K | Buy |
81,744
+2,043
| +3% | +$7.4K | ﹤0.01% | 1922 |
|
|
2024
Q1 | $256K | Sell |
79,701
-3,223
| -4% | -$10.3K | ﹤0.01% | 1973 |
|
|
2023
Q4 | $406K | Sell |
82,924
-47,093
| -36% | -$231K | ﹤0.01% | 1717 |
|
|
2023
Q3 | $709K | Sell |
130,017
-10,774
| -8% | -$58.7K | ﹤0.01% | 1311 |
|
|
2023
Q2 | $945K | Buy |
140,791
+67,288
| +92% | +$452K | ﹤0.01% | 1176 |
|
|
2023
Q1 | $649K | Buy |
73,503
+1,383
| +2% | +$12.2K | ﹤0.01% | 1263 |
|
|
2022
Q4 | $551K | Buy |
+72,120
| New | +$551K | ﹤0.01% | 1104 |
|